omniture
logo
Search
WUXI YAOMING UNITED BIOTECHNOLOGY CO. LTD
Media Room

Latest News

rss

WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards

SHANGHAI and SAN DIEGO, Nov. 7, 2024 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Compa...

2024-11-08 11:27 852
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards

WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth

* Revenue surged by 67.6% YoY to RMB 1,665 million * Gross profit surged by 133.4% to RMB 535 mi...

2024-08-20 23:05 2508
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth

WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones

* Revenue reached RMB 2,124 million, an increase of 114% compared with Year 2022 * Adjusted net...

2024-03-25 21:39 2238
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones

WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development

SHANGHAI, Jan. 30, 2024 /PRNewswire/ -- WuXi XDC (2268.HK), a leading global Contract Research, Dev...

2024-01-31 10:43 2909
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development

WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs)

SHANGHAI and INCHEON, South Korea, Jan. 23, 2024 /PRNewswire/ -- WuXi XDC(2268.HK), a leading globa...

2024-01-24 11:37 1456

WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development an...

2024-01-03 09:28 1732

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock c...

2023-11-17 14:00 2946

WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards

SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract, Resea­­rch, Developmen...

2023-10-20 16:00 1573
WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards

WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong

* Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation f...

2023-10-18 11:00 1507

WuXi XDC Launches New Commercial Manufacturing Facilities

* New commercial facilities offer one-stop manufacturing services for antibody intermediates, bio...

2023-09-20 18:51 1569

WuXi XDC and Boostimmune Sign MOU for Integrated Services

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development a...

2023-08-11 08:30 1583